Absence of Smooth Muscle Actin-Positive Pericyte Coverage of Tumor Vessels Correlates with Hematogenous Metastasis and Prognosis of Colorectal Cancer Patients
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objectives: Immature microvessels, which are not covered by pericytes, are irregular and leaky. We hypothesized that tumor cells can penetrate immature microvessels more easily than mature microvessels. In this study, we investigated the maturation of angiogenesis by the immunohistochemical staining of colorectal cancer specimens and determined the correlation between the microvessel count or the maturity of microvessels and clinicopathological variables. Methods: Ninety-two surgical specimens from our department were used. Double immunostaining of endothelial cells with anti-CD34 antibody and pericytes with anti-α-smooth muscle actin antibody was performed. The microvessel density (MVD) and microvessel pericyte coverage index (MPI) as an index of microvessel maturation were evaluated. Results: The MVD showed a significant positive correlation with tumor size, depth of invasion and Dukes’ stage. The MPI showed a significant positive correlation with the histological differentiation of the tumor tissues and distant metastasis at the time of operation. The high MVD group (≧26.0, n = 50) tended to have a poorer prognosis than the low MVD group (<26.0, n = 42) (p = 0.097). Next, the 50 patients in the high MVD group were classified into two subgroups of high MPI (≧78.1%, n = 25) and low MPI (<78.1%, n = 25). MPI showed a significant negative correlation with hematogenous metastasis, and the low MPI group demonstrated a significantly poorer survival than the high MPI group (p = 0.040). Conclusions: These findings demonstrate that immature neovascularization was observed in poorly differentiated tumors and was correlated with metastasis, resulting in a poorer prognosis. Taken together, not only microvessel density but also vascular maturation were crucial factors for colorectal cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“others indicated that therapeutic targets involving pericytes may exacerbate the process of tumor metastasis [31–34].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [32]
Citations
Cites
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“secrete angiopoietin-2 (Ang-2), resulting in the pericytes dissociating from pre-existing vessels. As a result, the endothelial cells can migrate, proliferate and assemble into tubes from pre-existing vessels in the presence of primarily vascular endothelial growth factor (VEGF) produced by tumor cells and stromal cel…”
BackgroundMolecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Benjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241 · cited 1×
“used 100-μm-thick sections in confocal microscopic studies looking at pericyte morphologies and pericyte coverage of vessels. A 4-μm section may not be indicative of pericyte coverage morphology. However, we examined whether microvessels were colocalized with α-SMA-positive pericytes or not and observed cross sections…”
BackgroundAbnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983 · cited 1×
“reported that pericytes expressed desmin, but not α-SMA, at the early stages of capillary sprouting in avian chorioallantoic membrane tumor angiogenesis assays. On the other hand, Morikawa et al. [”
BackgroundEberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
Pericytes in the microvasculature
Hirschi, K. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00063-6 · Cited by 775 · cited 1×
“reported that nonspecific CD34 immunostaining of leucocytes and other inflammatory cells can also occur. Therefore, in this study, we defined a microvessel as a lumen showing positive immunostaining for CD34 to avoid false positives.Pericytes cover capillaries and postcapillary venules and play a crucial role in influ…”
Background
Cited by
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
“Clinical studies, for example in bladder and colorectal cancer (O’Keeffe et al., 2008; Yonenaga et al., 2005), suggest that low pericyte coverage of the vasculature correlates with poor prognosis and increased metastases.”
BackgroundTumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“While several studies have shown that greater pericytes coverage corresponds to a better diagnosis [30] , others indicated that therapeutic targets involving pericytes may exacerbate the process of tumor metastasis [31] [32] [33] [34] .”
BackgroundPrinciples and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
“Absence of pericyte coverage around tumour vessels also correlates with metastasis in patient”
BackgroundNormalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Cooke, V. G., LeBleu, V. S., Keskin, D., Khan, Z., O'Connell, J. T., Teng, Y., Duncan, M. B., Xie, L., Maeda, G., Vong, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.024 · Cited by 530
“However, clinical data correlates low pericyte coverage with poor patient prognosis (O’Keeffe et al., 2008; Stefansson et al., 2006; Yonenaga et al., 2005), and disruption of pericytes has also been suggested to enhance metastasis (Xian et al., 2006).”
Ng, F., Ganeshan, B., Kozarski, R., Miles, K. A., & Goh, V. (2013) · Radiology · doi:10.1148/radiol.12120254 · Cited by 432
Dudley, A. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006536 · Cited by 424
“For example, deficient pericyte coverage, which can lead to vessel leakiness and hemorrhage, is associated with increased metastases in human cancers and in mouse tumor models (Yonenaga et al. 2005; Xian et al. 2006).”
BackgroundPericytes and vessel maturation during tumor angiogenesis and metastasis
Raza, A., Franklin, M. J., & Dudek, A. Z. (2010) · American Journal of Hematology · doi:10.1002/ajh.21745 · Cited by 382
Pericytes limit tumor cell metastasis
Xian, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25705 · Cited by 345
Determinants of metastatic competency in colorectal cancer
Tauriello, D. V. F., Calon, A., Lonardo, E., & Batlle, E. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12018 · Cited by 258
“The latter has been associated with metastasis and poor prognosis in patients with CRC (Yonenaga et al., 2005).”
BackgroundPericytes, an overlooked player in vascular pathobiology
Ferland-McCollough, D., Slater, S., Richard, J., Reni, C., & Mangialardi, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.008 · Cited by 230
“…low pericyte coverage leads to increased tumour cell invasiveness, while a high coverage is correlatedwith alowered rateof metastaticdissemina-tion (Yonenaga et al., 2005; Ito et al., 2013; Jayasinghe, Simiantonaki, and Kirkpatrick, 2015; Zang et al., 2015; Correa, Somoza, Lin, Schiemann, and…”
BackgroundAdaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 209
“…in the TME, participating in tumorigenesis, metastasis, TME remodeling, angiogenesis, and therapeutic resistance (Figure 4) (Luga et al., 2012; Yoshizaki et al., 2013; Jeppesen et al., 2014; Sung et al., 2015; You et al., 2015; Paolillo and Schinelli, 2017; Wang X. et al., 2018; Zeng et al.,…”
BackgroundCombined Effects of Pericytes in the Tumor Microenvironment
Ribeiro, A. L., & Okamoto, O. K. (2015) · Stem Cells International · doi:10.1155/2015/868475 · Cited by 168
“and breast cancer patients corroborated this finding [35, 40].”
ResultGriffioen, A. W., Mans, L. A., de Graaf, A. M. A., Nowak-Sliwinska, P. M., de Hoog, C. L. M. M., de Jong, T. A. M., Vyth‐Dreese, F. A., van Beijnum, J. R., Bex, A., & Jonasch, E. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0002 · Cited by 156
Richards, O. C., Raines, S. M., & Attie, A. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0035 · Cited by 164
“These findings directly translate to humans, because decreased -SMA-positive pericyte coverage of tumor vessels correlates with increased metastasis and results in a poorer prognosis (228).”
BackgroundAyoub, N. M., Jaradat, S. K., Al-Shami, K. M., & Alkhalifa, A. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838133 · Cited by 148
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 139
Physiologic Angiodynamics in the Brain
Dore-Duffy, P., & La Manna, J. C. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1713 · Cited by 132
“Pericytes appear to function at three stages of angiogenesis: (a) initiation (6, 56, 76, 92, 102), (b) sprout extension and connection (34, 67, 85), and (c) termination or maturation of newly formed vessels (7, 29, 81, 87, 93, 104).”
Role of the microenvironment in hepatocellular carcinoma development and progression
Wu, S., Ma, Y., Fang, Y., Liu, L., Fu, D., & Shen, X. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.010 · Cited by 145
Complexity of tumor vasculature in clear cell renal cell carcinoma
Qian, C., Huang, D., Wondergem, B., & Teh, B. T. (2009) · Cancer · doi:10.1002/cncr.24238 · Cited by 120
“The absence of pericyte coverage in tumor vasculature has been found to be associated with metastasis and poorer prognosis in patients with colorectal cancer.(40) Our study of CCRCC revealed that the undifferentiated microvessels, which are correlated with poor prognosis, are not covered by pericytes.”
BackgroundNanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
Wong, P., Muñoz‐Félix, J. M., Hijazi, M., Kim, H.-J., Robinson, S. D., de Luxán‐Delgado, B., Rodríguez‐Hernández, I., Maiques, Ó., Meng, Y.-M., Meng, Q., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.003 · Cited by 110
Staton, C. A., Chetwood, A., Cameron, I. C., Cross, S. S., Brown, N. J., & Reed, M. (2007) · Gut · doi:10.1136/gut.2007.125286 · Cited by 104
Yao, X., Qian, C.-N., Zhang, Z.-F., Tan, M.-H., Kort, E. J., Yang, X. J., Resau, J. H., & Teh, B. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0774 · Cited by 103
Tumour progression and metastasis
Arvelo, F. A., Sojo, F. J., & Cotte, C. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.617 · Cited by 114
“In fact, it has shown the existence of an inverted link between the contents in pericytes of tumour vessels and the number of metastasis in colorectal cancer patients [80].”
BackgroundWu, P., Han, J., Gong, Y., Liu, C., Yu, H., & Xie, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101990 · Cited by 111
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
Ruan, J., Luo, M., Wang, C., Fan, L., Yang, S. N., Cardenas, M., Geng, H., Leonard, J. P., Melnick, A., Cerchietti, L., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490763 · Cited by 93
“Finally, pericyte dysfunction and loss have been reported to lead to unexpectedly aggressive growth of some tumors with local invasion and distant metastasis both in a mouse model and in human patients.(45,46) In conclusion, this study provides evidence that the pericyte, through its dependence on PDGFRb signaling, re…”
Rajaganeshan, R., Prasad, R. K., Guillou, P. J., Chalmers, C. R., Scott, N., Sarkar, R., Poston, G. J., & Jayne, D. G. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603677 · Cited by 95
“Several methods have been described for determining tumour angiogenesis, including the use of Chalkley count (Hlatky et al, 2002), endothelial cell proliferation fraction (Hlatky et al, 2002), and pericyte coverage index (Yonenaga et al, 2005).”
MethodKocaba, V., Katikireddy, K. R., Gipson, I. K., Price, M. O., Price, F. W., & Jurkunas, U. V. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.2031 · Cited by 94
Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis
Zhang, Y., Cedervall, J., Hamidi, A., Herre, M., Viitaniemi, K., D’Amico, G., Miao, Z., Unnithan, R. V. M., Vaccaro, A., van Hooren, L., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3533 · Cited by 104
The Emerging Roles of Pericytes in Modulating Tumor Microenvironment
Sun, R., Kong, X., Qiu, X., Huang, C., & Wong, P.-P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676342 · Cited by 87
Pericytes on the Tumor Vasculature: Jekyll or Hyde?
Barlow, K. D., Sanders, A. M., Söker, S., Ergün, S., & Metheny‐Barlow, L. J. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0102-2 · Cited by 99
Dhar, K., Dhar, G., Majumder, M., Haque, I., Mehta, S., Veldhuizen, P. J. V., Banerjee, S. K., & Banerjee, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-209 · Cited by 93
“Recent studies reveal that pericytes limit metastatic spread in pancreatic b-islet cell tumorigenesis in PDGFRb mice [42] and in patients with colorectal cancer [43].”
BackgroundNisancioglu, M. H., Betsholtz, C., & Genové, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4245 · Cited by 87
“Moreover, an intriguing correlation was recently found between poor pericyte vessel coverage in primary colorectal cancer and increased metastatic events in human tumors (30).”
BackgroundThe gate to metastasis: key players in cancer cell intravasation
Sznurkowska, M. K., & Aceto, N. (2022) · The FEBS Journal · doi:10.1111/febs.16046 · Cited by 80
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
Lupo, G., Caporarello, N., Olivieri, M., Cristaldi, M., Motta, C., Bramanti, V., Avola, R., Salmeri, M., Nicoletti, F., & Anfuso, C. D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00519 · Cited by 90
“An increased amount of pericyte on the tumor microvessels inhibits the angiogenesis, while the absence of pericyte coverage correlates with metastasis in colorectal cancer patients (Yonenaga et al., 2005).”
BackgroundPericytes: A Double-Edged Sword in Cancer Therapy
Meng, M.-B., Zaorsky, N. G., Deng, L., Wang, H.-H., Chao, J., Zhao, L.-J., Yuan, Z.-Y., & Ping, W. (2015) · Future Oncology · doi:10.2217/fon.14.123 · Cited by 75
Pericytes in the Premetastatic Niche
Paiva, A. E., Lousado, L., Guerra, D. A. P., de Azevedo, P. O., Sena, I. F. G., Andreotti, J. P., Santos, G. S. P., Gonçalves, R., Mintz, A., & Birbrair, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3883 · Cited by 79
Quesada, A. R., Medina, M. Á., & Alba, E. (2007) · BioEssays · doi:10.1002/bies.20655 · Cited by 82
Chapter 14 Measuring Intratumoral Microvessel Density
Weidner, N. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02814-0 · Cited by 76
Complex interplay between tumor microenvironment and cancer therapy
Shen, M., & Kang, Y. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0663-7 · Cited by 80
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells
Hong, J., Tobin, N. P., Rundqvist, H., Li, T., Lavergne, M., García-Ibáñez, Y., Qin, H., Paulsson, J., Zeitelhofer, M., Adzemovic, M. Z., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv209 · Cited by 75
“Many reports have studied pericytes in human malignancies by αSMA staining (33,41).”
BackgroundEndosialin-Expressing Pericytes Promote Metastatic Dissemination
Viski, C., König, C., Kijewska, M., Mogler, C., Isacke, C. M., & Augustin, H. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0932 · Cited by 76
“Indeed, low pericyte coverage in clinical samples is associated with poor patient prognosis (42,43).”
BackgroundNano-targeting vascular remodeling in cancer: Recent developments and future directions
Giordo, R., Wehbe, Z., Paliogiannis, P., Eid, A. H., Mangoni, A. A., & Pintus, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.001 · Cited by 73
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
Shao, R., Taylor, S. L., Oh, D. S., & Schwartz, L. M. (2015) · Oncotarget · doi:10.18632/oncotarget.5943 · Cited by 71
“Consistent with these findings, decreased PC/SMC coverage around vessels in patients with colorectal cancer is correlated with enhanced cancer metastasis [96].”
Drug resistance associated with antiangiogenesis therapy
Eikesdal, H. P., & Kalluri, R. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.006 · Cited by 74
“On the other hand absence of αsmooth muscle actin (αSMA) positive cells around the blood vessels correlates with hematogenous metastasis and poor prognosis in colorectal cancer patients [49], indicating that pericyte coverage on the tumor vasculature may protect against metastasis.”
BackgroundAngiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice
Yang, S., Fang, Y., Ma, Y., Wang, F., Wang, Y., Jia, J., Yang, Y., Sun, W., Zhou, Q., & Li, Z. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70313 · Cited by 71
Perrot, C. Y., Herrera, J. L., Fournier-Goss, A. E., & Komatsu, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68019-w · Cited by 65
Perivascular niches: critical hubs in cancer evolution
Nowosad, A., Marine, J., & Karras, P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.010 · Cited by 62
Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels
Hosack, L. W., Firpo, M. A., Scott, J., Prestwich, G. D., & Peattie, R. A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.033 · Cited by 63
“Extensive research suggests that nascent microvessels are complete and stable once fully ensheathed by pericytes [14–16].”
BackgroundMethodTumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery
Kim, S. J., Jung, K. H., Son, M. K., Park, J. H., YAN, H. H., Fang, Z., Kang, Y. W., Han, B., Lim, J. H., & Hong, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.035 · Cited by 61
Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome
Guerra, D. A. P., Paiva, A. E., Sena, I. F. G., de Azevedo, P. O., da Silva, W. N., Mintz, A., & Birbrair, A. (2018) · Angiogenesis · doi:10.1007/s10456-018-9621-x · Cited by 60
Sun, X., & Zhang, H. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-43 · Cited by 68
“It seems that α-SMA and desmin expression are esentially identical in pericytes [12,45].”
BackgroundMethodInfluentialHypercoagulation in colorectal cancer: What can platelet indices tell us?
Seretis, C., Youssef, H., & Chapman, M. (2014) · Platelets · doi:10.3109/09537104.2014.894969 · Cited by 56
Ma, Z., Shou, K., Li, Z., Jian, C., Qi, B., & Yu, A. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3083 · Cited by 56
Cao, M., Yie, S.-M., Wu, S., Chen, S., Lou, B., He, X., Ye, S.-R., Xie, K., Rao, L., Gao, E., et al. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9274-7 · Cited by 56
“Vascular invasion was assessed by measuring microvessel density (MVD) in 86 cases of tumors that were performed with anti-CD34 immunohistochemical stain [ 21 ].”
MethodThe tumour microenvironment of pituitary neuroendocrine tumours
Marques, P., Grossman, A. B., & Korbonits, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100852 · Cited by 57
Pathophysiological Mechanisms of Angiogenesis
Walsh, D. A. (2007) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)44006-9 · Cited by 54
HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
Bao, W., Fu, H., Jia, L., Zhang, Y., Li, W., Jin, B., Yao, L.-B., Chen, S., & Yang, A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.009 · Cited by 50
Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization
Jaggi, J. S., Henke, E., Seshan, S. V., Kappel, B. J., Chattopadhyay, D., May, C., McDevitt, M. R., Nolan, D., Mittal, V., Benezra, R., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000267 · Cited by 57
“An inverse correlation between pericyte coverage and hematogenous spread has also been observed in colorectal cancer patients [37].”
BackgroundWang, Y., Yao, X., Ge, J., Hu, F., & Zhao, Y. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/102736 · Cited by 55
“Further examination of the associations between MVD and clinicopathological factors used 25 studies [1, 3, 16, 17, 23, 32, 46, 49, 54, 55, 57, 61–74].”
MethodHansen, T. F., Sørensen, F. B., Spindler, K. G., Olsen, D. A., Andersen, R. F., Lindebjerg, J., Brandslund, I., & Jakobsen, A. K. M. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0878-8 · Cited by 48
“Furthermore, a differentiation between mature and immature microvessels may provide additional information [ 12 ].”
BackgroundIdentification of the S100 fused-type protein hornerin as a regulator of tumor vascularity
Gutknecht, M. F., Seaman, M. E., Ning, B., Cornejo, D. A., Mugler, E., Antkowiak, P. F., Moskaluk, C. A., Hu, S. N., Epstein, F. H., & Kelly, K. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00488-6 · Cited by 48
KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer
Kang, Y. W., Lee, J. E., Jung, K. H., Son, M. K., Shin, S., Kim, S., Fang, Z., YAN, H. H., Park, J. H., Han, B., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.013 · Cited by 45
Welén, K., Jennbacken, K., Tešan, T., & Damber, J. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.33 · Cited by 45
HGF/c-Met Signalling in the Tumor Microenvironment
Zambelli, A., Biamonti, G., & Amato, A. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_2 · Cited by 45
Francescone, R., Ngernyuang, N., Yan, W., Bentley, B. A., & Shao, R. (2013) · Oncogene · doi:10.1038/onc.2013.160 · Cited by 39
A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers
Augsten, M., Hägglöf, C., Peña, C., & Östman, A. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0040-9 · Cited by 40
“The potential prognostic significance of pericyte coverage, and of different pericyte subsets, remains poorly characterized, although some studies have demonstrated that reduced pericyte coverage is correlated with metastasis and bad prognosis [59].”
BackgroundHeterogeneity of angiogenesis and blood vessel maturation in cartilage tumors
Kalinski, T., Sel, S., Kouznetsova, I., Röpke, M., & Roessner, A. (2009) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.12.008 · Cited by 38
Hill, J. J., Tremblay, T., Pen, A., Li, J., Robotham, A. C., Lenferink, A. E. G., Wang, E., O'Connor‐McCourt, M. D., & Kelly, J. F. (2011) · Journal of Proteome Research · doi:10.1021/pr101267k · Cited by 42
Recent advances in tumor vasculature targeting using liposomal drug delivery systems
Lila, A. S. A., Ishida, T., & Kiwada, H. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903289928 · Cited by 38
“These characteristics make tumor vessels more leaky than normal vessels [23,24].”
BackgroundMorrissey, C. M., Dowell, A., Koreckij, T. D., Nguyen, H. M., Lakely, B., Fanslow, W. C., True, L. D., Corey, E., & Vessella, R. L. (2010) · The Prostate · doi:10.1002/pros.21216 · Cited by 34
Hara, T., Monguchi, T., Iwamoto, N., Akashi, M., Mori, K., Oshita, T., Okano, M., Toh, R., Irino, Y., Shinohara, M., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309721 · Cited by 34
The ArfGAP ASAP1 Controls Actin Stress Fiber Organization via Its N-BAR Domain
Gasilina, A., Vitali, T., Luo, R., Jian, X., & Randazzo, P. A. (2019) · iScience · doi:10.1016/j.isci.2019.11.015 · Cited by 33
Characterization of a novel metastatic prostate cancer cell line of LNCaP origin
Castanares, M. A., Copeland, B. T., Chowdhury, W. H., Liu, M. M., Rodríguez, R., Pomper, M. G., Lupold, S. E., & Foss, C. A. (2015) · The Prostate · doi:10.1002/pros.23115 · Cited by 32
“It has been shown that this deficiency correlates to increased metastases in both animal models [33] and humans [34].”
BackgroundVarga, I., Kyselovič, J., Danišovič, Ľ., Gálfiová, P., Kachlík, D., Polák, Š., & Klein, M. (2018) · Biologia · doi:10.2478/s11756-018-0162-y · Cited by 32
Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients’ Outcome
Galindo-Pumariño, C., Collado, M., Herrera, M., & Peña, C. (2021) · Cancers · doi:10.3390/cancers13051130 · Cited by 31
“Thus, absence of smooth muscle actin-positive pericytes in primary tumors or different subsets of perivascular cells defined by PDGF receptor-α and -β are associated with liver metastasis and mCRC patients’ survival [60,61].”
BackgroundWang, H., Wang, B., Chen, M., Li, S., Chen, H., Xu, W. F., & Zhang, J. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.07.042 · Cited by 31
Larghero, P., Venè, R., Minghelli, S., Travaini, G., Morini, M., Ferrari, N., Pfeffer, U., Noonan, D. M., Albini, A., & Benelli, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl233 · Cited by 31
Resistance to angiogenesis inhibitors in renal cell carcinoma.
Tamaskar, I., Dhillon, J., & Пили, Р. (2011) · PubMed · Cited by 33
Lu, J., Hu, D., Tang, H., Hu, X., Shen, Y., Li, Z., Yang, P., & Kamel, I. R. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.03.021 · Cited by 30
Immunotherapeutic Targeting of Tumor-Associated Blood Vessels
Fabian, K. P., & Storkus, W. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_13 · Cited by 30
Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis
Stratopoulou, C. A., Camboni, A., Donnez, J., & Dolmans, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194585 · Cited by 30
Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development
Thapa, K., Khan, H., Kaur, G., Kumar, P., & Singh, T. G. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149130 · Cited by 31
Zhu, J., Wu, Y., Ma, J., He, H., Liu, Z., Zhu, X., He, X., He, J., Chen, Z., Jin, X., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00078-5 · Cited by 30
“A previous study has unveiled that low pericyte coverage in patients ’ tumors is associated with increased metastasis and poor prognosis (Yonenaga et al, 2005).”
Nairon, K. G., DePalma, T. J., Zent, J. M., Leight, J. L., & Skardal, A. (2022) · iScience · doi:10.1016/j.isci.2022.104645 · Cited by 27
“These destabilized, low coverage vessels have been shown in prior work to lead to increased tumor cell extravasation and metastatic invasion (He et al., 2020; Yonenaga et al., 2005).”
BackgroundDíaz‐Flores, L., Gutiérrez, R., García, M. P., González‐Gómez, M., Díaz-Flores, L., Carrasco, J. L., Madrid, J. F., & Bello, A. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169010 · Cited by 28
Reduction of Calponin h1 expression in human colon cancer blood vessels
Yanagisawa, Y., Takeoka, M., Ehara, T., Itano, N., Miyagawa, S., & Taniguchi, S. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.05.010 · Cited by 26
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
Zhang, L., Pakmehr, S., Shahhosseini, R., Hariri, M., Fakhrioliaei, A., Shayan, F. K., Xiang, W., & Shayan, S. K. (2023) · Medical Oncology · doi:10.1007/s12032-023-02233-0 · Cited by 30
“The defective structure of tumor endothelial cells (TECs) (i.e., have fewer pericytes) can lead to blood vessel leakage and bleeding, and has been linked to an increase in metastasis in human cancers [28, 29].”
BackgroundEnhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
Ito, S., Miyashita, H., Suzuki, Y., Kobayashi, M., Satomi, S., & Sato, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073931 · Cited by 26
“It was previously documented that deficient coverage of tumor blood vessels by mural cells is accompanied by an increased incidence of metastasis of human colorectal carcinoma cells [23].”
BackgroundHistopathological features predict metastatic potential in locally advanced colon carcinomas
Jayasinghe, C., Simiantonaki, N., & Kirkpatrick, C. J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1013-7 · Cited by 24
“In another study immature microvessels without pericyte coverage were described in correlation with haematogenous metastasis of CC [39].”
BackgroundIesato, A., Li, S., Roti, G., Hacker, M. R., Fischer, A. H., & Nucera, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab552 · Cited by 23
Pei, X., Liu, Z., Tang, L., Zhang, J., He, Y., Zhuang, X., Song, Y., Peng, S., He, Y., Zhao, Y., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02341-9 · Cited by 24
Biological mechanisms of microvessel formation in advanced atherosclerosis: The big Five
Cheng, C., Chrifi, I., Pasterkamp, G., & Duckers, H. J. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.10.004 · Cited by 24
Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis
Minami, Y., Sasaki, T., Bochimoto, H., Kawabe, J.-I., Endo, S., Hira, Y., Watanabe, T., Okumura, S., Hasebe, N., & Ohsaki, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2783 · Cited by 22
Iesato, A., & Nucera, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_14 · Cited by 20
Metadata
- Authors
- Yonenaga, Y., Mori, A., Onodera, H., Yasuda, S., Oe, H., Fujimoto, A., Tachibana, T., & Imamura, M.
- Affiliations
- Kyoto University (JP)
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 69
- Issue
- 2
- Pages
- 159-166
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W2012328307
- Cited by
- 203
- References
- 39
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 3 · 2023: 13 · 2022: 13 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 11 · 2017: 15 · 2016: 12 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 9
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Oncology (publishedVersion)
- PubMed (publishedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- colorectal cancer, tumor angiogenesis, microvessel density, pericyte coverage, alpha-smooth muscle actin, hematogenous metastasis, prognosis, tumor differentiation, Dukes stage, survival
- MeSH terms
- Actins, Adult, Aged, Aged, 80 and over, Capillary Permeability, Cell Transformation, Neoplastic, Female, Follow-Up Studies, Humans, Immunohistochemistry, Male, Middle Aged, Muscle, Smooth, Vascular, Neoplastic Cells, Circulating, Neoplasm Invasiveness, Neoplasm Metastasis, Neovascularization, Pathologic, Prognosis, Colorectal Neoplasms, Survival Analysis, Antigens, CD34, Pericytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.